Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 68 results found. Search for [ pfizer vaccine efficacy 95% ]

Results 1 to 21 of 68
Reuters
January 25, 2021
India's Central Drugs Standard Control Organisation (CDSCO) says Pfizer officials failed to turn up to meetings after the company's application was made in early December


Manoj Sharma
January 5, 2021
There was immense pressure on governments to develop a vaccine at the earliest due to the destruction COVID-19 pandemic was unleashing. This led to a race among pharma companies to be the first to develop a vaccine


BusinessToday.In
December 30, 2020
This development comes hours after the UK government accepted the recommendation from the Medicines and Healthcare Regulatory Agency (MHRA) to authorise Oxford University-AstraZeneca's Covid-19 vaccine, named Covishield, for emergency use


BusinessToday.In
December 29, 2020
Serum Institute of India (SII) CEO Adar Poonawalla said on December 28, that the vaccine is likely to get an emergency-use licence from the UK Medicines and Healthcare products Regulatory Agency as well as the Indian regulator, Drugs Controller General of India (DCGI), by early January


BusinessToday.In
December 29, 2020
Poonawalla says Covishield shows efficacy level of 95 per cent provided two shots are taken after a gap of 2-3 months; AstraZeneca will make that public with documentation soon, he adds


BusinessToday.In
December 29, 2020
The chief executive of Serum Institute - the biggest vaccine maker in the world by volume - said all trial data for Covishield has been provided to authorities in the UK and India as \"nobody wants to risk safety\"


BusinessToday.In
December 27, 2020
Soriot said, \"We think we have figured out the winning formula and how to get efficacy that, after two doses, is up there with everybody else\"


PTI
December 27, 2020
The Oxford vaccine, which also has a tie-up with the Serum Institute of India, is expected to win approval in the UK before Thursday, speeding up the provision of the jab to the most vulnerable groups


BusinessToday.In
December 19, 2020
Despite the rise in cases, India's Covid-19 recoveries have witnessed a steep exponential rise -- from 50,000 in May to over 95 lakh in December. Recoveries are more than 30 times active cases, says  HealthMin


BusinessToday.In
December 15, 2020
The US and Canada began the vaccination drive against coronavirus with Pfizer-BioNTech doses on Monday. Both countries have started administering the coronavirus vaccine shots to healthcare workers and elderly citizens this week


BusinessToday.In
December 12, 2020
US President Donald Trump says: \"We've delivered a safe and effective vaccine in just 9 months. This is one of the greatest scientific accomplishments in history\"


PB Jayakumar
December 11, 2020
Sputnik V in India: India's Dr Reddy's Laboratories and Hetero Drugs have a license to sell 100 million doses of the vaccine in India and limited trials are also being done in the country, as part of the approval process


BusinessToday.In
December 9, 2020
Albert Bourla, the CEO of Pfizer, said the company will have tiered pricing for the middle-income countries (including, India) and will give the vaccine free in Africa


Reuters
December 8, 2020
In total, Britain has ordered 40 million doses of the Pfizer/BioNTech shot. As each person requires two doses, that is enough to vaccinate 20 million people in the country of 67 million


BusinessToday.In
December 7, 2020
Pfizer's clarification comes as experts believe that storing the vaccine in minus 70 degree Celsius would be a big hurdle


BusinessToday.In
December 7, 2020
On December 2, the UK became the first nation to approve Pfizer-BioNTech vaccine against COVID-19 for emergency use; Bahrain has also approved vaccine candidate 'BNT162b2'. India decision on vaccine could come this week


BusinessToday.In
December 6, 2020
Total number of people who have recuperated from disease has crossed 91 lakh, pushing national recovery rate to 94.37 per cent, according to Union Health Ministry data


BusinessToday.In
December 6, 2020
Pfizer Inc submitted application to DCGI seeking emergency use authorisation on Dec 4; also seeks permission to import vaccine for sale and distribution in India


BusinessToday.In
December 5, 2020
On December 2, the UK became the first country in the world to approve Pfizer and BioNTech coronavirus candidate BNT162b2 after the Medicines and Healthcare Products Regulatory Agency found the jab safe for widespread rollout


BusinessToday.In
December 5, 2020
Confirmation of approval by National Health Regulatory Authority of Bahrain followed thorough analysis and review undertaken by authority of all available data


PAGES 1 OF 4  1234